A 64-year-old man presented with progressive skin lesions, which were diagnosed as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and were confirmed with marrow involvement. He received SL-401 chemotherapy but developed persistent monocytosis. A 3-month follow-up bone marrow biopsy showed characteristic "tadpole" cells on smears ( BPDCN is an aggressive neoplasm that can be associated with other myeloid malignancies. Its association with CMML is of particular interest because CMML cases may also contain plasmacytoid dendritic cell nodules. Our case demonstrated immunophenotypic correlation between these 2 entities: both share expressions of CD4, CD38, CD56, CD123, and HLA-DR, but lack CD117. Further exploration of the immunophenotypic relationship may shed some light on the mechanism of their transformation.
BPDCN is an aggressive neoplasm that can be associated with other myeloid malignancies. Its association with CMML is of particular interest because CMML cases may also contain plasmacytoid dendritic cell nodules. Our case demonstrated immunophenotypic correlation between these 2 entities: both share expressions of CD4, CD38, CD56, CD123, and HLA-DR, but lack CD117. Further exploration of the immunophenotypic relationship may shed some light on the mechanism of their transformation.
